ProShare Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,367
| Closed | -$636K | – | 2463 |
|
|
2021
Q1 | $636K | Sell |
5,367
-619
| -10% | -$73.4K | ﹤0.01% | 1289 |
|
|
2020
Q4 | $707K | Sell |
5,986
-232
| -4% | -$27.4K | ﹤0.01% | 1056 |
|
|
2020
Q3 | $691K | Buy |
6,218
+68
| +1% | +$7.56K | ﹤0.01% | 825 |
|
|
2020
Q2 | $628K | Buy |
6,150
+850
| +16% | +$86.8K | ﹤0.01% | 856 |
|
|
2020
Q1 | $572K | Sell |
5,300
-3,031
| -36% | -$327K | ﹤0.01% | 707 |
|
|
2019
Q4 | $970K | Sell |
8,331
-2,027
| -20% | -$236K | ﹤0.01% | 804 |
|
|
2019
Q3 | $1.19M | Sell |
10,358
-1,007
| -9% | -$115K | 0.01% | 708 |
|
|
2019
Q2 | $1.08M | Sell |
11,365
-2,007
| -15% | -$191K | 0.01% | 733 |
|
|
2019
Q1 | $1.22M | Buy |
13,372
+32
| +0.2% | +$2.92K | 0.01% | 708 |
|
|
2018
Q4 | $1.01M | Sell |
13,340
-1,857
| -12% | -$141K | 0.01% | 700 |
|
|
2018
Q3 | $1.22M | Buy |
15,197
+1,272
| +9% | +$102K | 0.01% | 741 |
|
|
2018
Q2 | $1.38M | Buy |
13,925
+1,160
| +9% | +$115K | 0.01% | 720 |
|
|
2018
Q1 | $1.03M | Sell |
12,765
-2,110
| -14% | -$171K | 0.01% | 805 |
|
|
2017
Q4 | $1.17M | Sell |
14,875
-466
| -3% | -$36.7K | 0.01% | 772 |
|
|
2017
Q3 | $1.42M | Buy |
15,341
+1,380
| +10% | +$127K | 0.01% | 645 |
|
|
2017
Q2 | $1.58M | Sell |
13,961
-549
| -4% | -$62.1K | 0.02% | 615 |
|
|
2017
Q1 | $1.45M | Sell |
14,510
-3,419
| -19% | -$342K | 0.02% | 647 |
|
|
2016
Q4 | $1.93M | Buy |
17,929
+617
| +4% | +$66.3K | 0.02% | 561 |
|
|
2016
Q3 | $2.16M | Sell |
17,312
-2,481
| -13% | -$309K | 0.03% | 465 |
|
|
2016
Q2 | $2.1M | Buy |
19,793
+109
| +0.6% | +$11.6K | 0.03% | 493 |
|
|
2016
Q1 | $2.25M | Sell |
19,684
-1,652
| -8% | -$189K | 0.03% | 423 |
|
|
2015
Q4 | $3.04M | Buy |
+21,336
| New | +$3.04M | 0.04% | 390 |
|